Drug induced haematotoxicity
Abstract
The main types of hematological complications related to ongoing pharmacotherapy - (different types of cytopenia, as well as coagulopathy) are presented. The risk factors and mechanisms of development of these disorders are discussed. The authors emphasize the importance of awareness by doctors of the existence of drug induced pathology (disease) as a separate type of iatrogeny.
About the Authors
S. S. Postnikov
Pirogov Russian National Research Medical University; Central State Pediatric Hospital
Russian Federation
Russian Federation
M. N. Kostylyova
Pirogov Russian National Research Medical University; Central State Pediatric Hospital
Russian Federation
Russian Federation
A. N. Gratsianskaya
Pirogov Russian National Research Medical University; Central State Pediatric Hospital
Russian Federation
Russian Federation
A. E. Ermilin
Pirogov Russian National Research Medical University; Central State Pediatric Hospital
Russian Federation
Russian Federation
References
1. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum. Psychopharmacol. Clin. Exp. 2008; 23: 27–41.
2. Bloom J. Principles of Hematotoxicology: Laboratory Assessment and Interpretation of Data. Toxicol Pathol March 1993; 21 (2): 130–134.
3. Anastasov A, Petrov Ì. Drug induced haematotoxicity. In.:Madjrakov G, Pophristov P, eds. Drug disease. Sofia: Meditsina and sport; 1973. P. 307–349.
4. Zborovsky AB, Turenkov IN, Belousov YuB. Drug induced haematotoxicity. In.: Adverse side effects of drugs. Ìoscow: Meditsinskoe informatsionnoe agentstvo; 2008. P. 449–487.
5. Barbaryan A, Iyinagoro C, Nwankwo N et al. Ibuprofen-Induced Hemolytic Anemia. Case Reports in Hematology 2013; Article ID 142865, 3 pages.
6. Marik PE, Parekh P. Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis. BMJ Case Reports. 2013; 2013: bcr2012007801. doi:10.1136/bcr-2012-007801.
7. Chen F, Zhan Z. Severe drug-induced immune haemolytic anaemia due to ceftazidime. Blood Transfusion. 2014; 12 (3): 435–437. doi:10.2450/2014.0237-13.
8. Mintzer DM, Billet SN, Chmielewsk L. Drug-Induced Hematologic Syndromes. Advances in Hematology 2009; Article ID 495863, 11 pages. doi:10.1155/2009/495863.
9. Ammus S. et al. Drug-induced red cell dyscrasias. Blood Reviews 1989; 3 (2): 71 — 82.
10. Li E, Ceja E, Hoffman JM. Anemias. In: Tisdale JE, Miller DA, edts. Drug-induced Diseases: Prevention, Detection, and Management. Bethesdà; 2010. P. 973–87.
11. Erythrocyte enzimopathies. In.: Taschev T, edt. Congenital and aquire enzymipathies. Moscow: Meditsina; 1980. P. 72–90.
12. Postnikov SS, Galaeva SS, Galaev VS. An unusual side effect of azythromicin in 5 years child. Lechebnoe delo 2006; 3: 84–85.
13. Plachouras, D, Giannitsioti E, Athanassia S, Kontopidou F, Papadopoulos A, Kanellakopoulou K, Giamarellou H. Clinical Infectious Diseases 2006; 43(9): e89–e91.
14. Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic Effects of Linezolid: Summary of Clinical Experience. Antimicrobial Agents and Chemotherapy 2002; 46(8): 2723–2726.
15. William Â,. McNamee Jr. Resumption of Linezolid Therapy after Myelotoxicity, Clinical Infectious Diseases 2003; P. 741–742.
16. Monson T, Schichman SA, Zent CS. Linezolid-Induced Pure Red Blood Cell Aplasia. Clinical Infectious Diseases 2002; 35 (3): e29–e31.
17. Shukla P, Bansode FW, Singh RK. Chloramphenicol toxicity: A review. J Med Sci 2011; 2:1313–1316.
18. Gusel VA, Markova IV. Directory of pediatric clinical pharmacology. Leningrad: Meditsina; 1989.
19. Fausel CA. Neutropenia and agranulocytosis. Â êí.: Tisdale JE, Miller DA, ðåä. Drug-induced Diseases: Prevention, Detection, and Management. Bethesdà; 2010. P. 973–87.
20. Padeyskaya EN. Co-trymaxozol (Biseptol). The value in current clinical practice and application recommendation. Ìoscow: Medpractika-M; 2003.
21. Belousov YuB, Gurevich KG. Haematopoietic system adverse reactions. In: General and private clinical pharmacokinetics. Ìoscow: 2006. P. 432–34.
22. Jones KL, Kiel PJ. Thrombocytopenia. In.: Tisdale JE, Miller DA, edts. Drug- induced Diseases: Prevention, Detection, and Management. Bethesdà; 2010. P. 929–90.
23. Kaufman DW, Kelly JP, Johannes CB et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993; 82 (9): 2714–2718.
24. Young LS. Hematologic Effects of Linezolid versus Vancomycin. Clin Infect Dis 2004; 38 (8): 1065–1066.
25. Natsumoto B, Yokota K, Omata F, Furukawa K. Risk factors for linezolid- associated thrombocytopenia in adult patients. Infection. 2014; 42(6): 1007–1012.
26. Papaioannides D, Bouropoulos C, Korantzopoulos Ð. Co-trimoxazole induced acute thrombocytopenic purpura. Emerg Med J 2003;20:e3.
27. Hudaoglu O, Tokgöz Y. Acute Lymphoblastic Leukemia in Association with Long Term Exposure to Trimethoprim- Sulfomethaxozole. Indian pediatrics 2007; 44(4): 311–2.
28. Garweod CL. Thromboembolic diseases». In: Tisdale JE, Miller DA, edts. Drug- induced Diseases: Prevention, Detection, and Management. Bethesda; 2010. P. 941–61.
29. Nasonov EL. The use of non-staroidal anti-inflammatory drug in medicine in the early 21st century. RMJ 2003; 11 (7): 375–378.
30. Sychev DA, Ramenskaya GV, Ignatiev IV, Kukes VG. Clinical pharmacogenetics. Kukes VG, Bochkova NP, edts. Moscow: GEOTAR-Media; 2007.
Review
For citations:
Postnikov S.S., Kostylyova M.N., Gratsianskaya A.N., Ermilin A.E. Drug induced haematotoxicity. Safety and Risk of Pharmacotherapy. 2016;(3):28-35. (In Russ.)
Views:
2094
Email this article 